US Patent

US8039451 — Boron-containing small molecules

Composition of Matter · Assigned to Anacor Pharmaceuticals LLC · Expires 2029-06-29 · 3y remaining

Vulnerability score 10/100 Ironclad — strong claim type, well-established, deep family

What this patent protects

This patent protects boron-containing compounds useful for treating fungal infections, particularly onychomycosis and cutaneous fungal infections, through topical application.

USPTO Abstract

This invention relates to compounds useful for treating fungal infections, more specifically topical treatment of onychomycosis and/or cutaneous fungal infections. This invention is directed to compounds that are active against fungi and have properties that allow the compound, when placed in contact with a patient, to reach the particular part of the skin, nail, hair, claw or hoof infected by the fungus. In particular the present compounds have physiochemical properties that facilitate penetration of the nail plate.

Drugs covered by this patent

Patent Metadata

Patent number
US8039451
Jurisdiction
US
Classification
Composition of Matter
Expires
2029-06-29
Drug substance claim
Yes
Drug product claim
Yes
Assignee
Anacor Pharmaceuticals LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.